Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Avatar Builder | Contact Info | Update Email | Update Password | Leaderboards | Manage Favourite | Reputation | Reputation History | Subscriptions | Payment Info | Invoices | Favourites

Bullboard Post History

by TaylorSwifft

Order by:

PFE	Kevin Harrington Discusses FSD Pharma {^youtubevideo\|(width)560\|(height)340\|(rel)False\|(url)https://www.youtube.com... April 13, 2023
LUV	Kevin Harrington Discusses FSD Pharma {^youtubevideo\|(width)560\|(height)340\|(rel)False\|(url)https://www.youtube.com... April 13, 2023
LUV	FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On... July 14, 2022
PFE	FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On... July 14, 2022
PFE	FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance {^youtubevideo\|(width)560\|(height)340\|(rel)False\|(url)https://www.youtube.com... June 3, 2022
LUV	FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance {^youtubevideo\|(width)560\|(height)340\|(rel)False\|(url)https://www.youtube.com... June 3, 2022
LUV	FSD Pharma Files Investigational New Drug Application “IND” FSD Pharma Files Investigational New Drug Application (“IND”) ... June 1, 2022
PFE	FSD Pharma Files Investigational New Drug Application “IND” FSD Pharma Files Investigational New Drug Application (“IND”) ... June 1, 2022
PFE	FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets ... May 10, 2022
LUV	FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets ... May 10, 2022
PFE	Lucid-MS for Multiple Sclerosis Treatment {^youtubevideo\|(width)560\|(height)340\|(rel)False\|(url)https://www.youtube.com... May 1, 2022
LUV	Lucid-MS for Multiple Sclerosis Treatment {^youtubevideo\|(width)560\|(height)340\|(rel)False\|(url)https://www.youtube.com... April 30, 2022
PFE	"Julia Levy Award" Recipient David Allan and Dr. John McGraw FSD Pharma Appoints Julia Levy Award Recipient David Allan and Dr. John... April 24, 2022

Featured Company

Mullen Group Ltd. T.MTL

Mullen Group is one of North America's largest logistics providers with a network of independently operated businesses ... view more »